Australia markets close in 2 hours 7 minutes

Relay Therapeutics, Inc. (RLAY)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
7.50-0.45 (-5.66%)
At close: 04:00PM EDT
7.68 +0.18 (+2.40%)
After hours: 06:08PM EDT
Full screen
Trade prices are not sourced from all markets
Previous close7.95
Open7.91
Bid9.59 x 1800
Ask10.01 x 800
Day's range7.41 - 7.91
52-week range5.95 - 19.23
Volume1,613,891
Avg. volume1,044,338
Market cap983.842M
Beta (5Y monthly)1.66
PE ratio (TTM)N/A
EPS (TTM)-2.79
Earnings date02 May 2024 - 06 May 2024
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target est23.05
  • Insider Monkey

    11 Oversold Biotech Stocks To Buy Right Now

    In this article, we will be taking a look at 11 oversold biotech stocks to buy right now. To skip our detailed analysis of the biotech sector, you can go directly to see the 5 Oversold Biotech Stocks To Buy Right Now. Dealmaking in Biotech Healthcare has been performing well so far in 2024, and […]

  • Zacks

    Does Relay Therapeutics, Inc. (RLAY) Have the Potential to Rally 146.52% as Wall Street Analysts Expect?

    The mean of analysts' price targets for Relay Therapeutics, Inc. (RLAY) points to a 146.5% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.

  • GlobeNewswire

    Relay Therapeutics to Participate in Three Upcoming Investor Conferences

    CAMBRIDGE, Mass., Feb. 26, 2024 (GLOBE NEWSWIRE) -- Relay Therapeutics, Inc. (Nasdaq: RLAY), a clinical-stage precision medicine company transforming the drug discovery process by combining leading-edge computational and experimental technologies, today announced that management will participate in three upcoming fireside chats: TD Cowen’s 44th Annual Health Care Conference on Monday, March 4, 2024 at 10:30 a.m. ETLeerink Partners’ 2024 Global Biopharma Conference on Monday, March 11, 2024 at 10